Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
High levels of ALT (p < 0.001), AST (p < 0.001), ALP (p < 0.001), CRP (p < 0.001), ESR (p < 0.001), FBS (p = 0.043) and creatinine (p < 0.001) and low levels of TG (p = 0.005), LDL (p < 0.001), uric acid (p < 0.001), real-time PCR Ct value (p = 0.008),and 25-hydroxyvitamin D (p < 0.001) were strongly linked with the severity of COVID-19.
Source: Baseline characteristics of COVID-19 patients. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The blood samples of COVID-19 patients were taken from November 2020 to February 2022, one week post the initiation of infection.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19
Study design awaiting verification · Future Virology · 2023
Original publication title
Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19
© 2023 Future Medicine Ltd
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
The present study aimed to determine a correlation between differential TRIM56 expression levels and severe infections of COVID-19 between the Alpha, Delta and Omicron BA.5 variants.
Source: Aim:Abstract: Materials & methods
This study was performed on 330 COVID-19 patients, including 142 with severe and 188 with mild infections, as well as 160 healthy controls. The levels of TRIM56 gene expression were determined using a qPCR.
Source: Materials & methods:Abstract: Results
TRIM56 gene showed significantly lower mRNA expression in the severe and mild groups compared with healthy individuals. Our finding indicated the high and low reduction of TRIM56 mRNA expression in Delta and Omicron BA.5 variant, respectively.
Source: Results:Abstract: Conclusion
Further research is needed to characterize the impact of TRIM proteins on the severity of COVID-19.
Source: Conclusion:Authors’ abstract
Aim:
The present study aimed to determine a correlation between differential TRIM56 expression levels and severe infections of COVID-19 between the Alpha, Delta and Omicron BA.5 variants.
Materials & methods:
This study was performed on 330 COVID-19 patients, including 142 with severe and 188 with mild infections, as well as 160 healthy controls. The levels of TRIM56 gene expression were determined using a qPCR.
Results:
TRIM56 gene showed significantly lower mRNA expression in the severe and mild groups compared with healthy individuals. Our finding indicated the high and low reduction of TRIM56 mRNA expression in Delta and Omicron BA.5 variant, respectively.
Conclusion:
Further research is needed to characterize the impact of TRIM proteins on the severity of COVID-19.
Plain language summary
Scientists looked at a protein called TRIM that helps fight viruses to see if a specific TRIM protein, TRIM56, was linked to how poorly people became with COVID-19. The study looked at the blood samples of 330 patients and found that COVID-19 patients had less TRIM56 than healthy people, especially those who were particularly ill.
Tweetable abstract
#Tavakoli et al. discovered that the TRIM56 gene, which plays a crucial role in the body's immune response to viruses, is likely associated with severe COVID-19 infections.
Publication and source details
Original title: Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19
Rezvan Tavakoli; Pooneh Rahimi; Mojtaba Hamidi-Fard; Sana Eybpoosh; Delaram Doroud; Iraj Ahmadi; Enayat Anvari; Mohammadreza Aghasadeghi; Abolfazl Fateh
Future Virology · 2023
* Author for correspondence: Tel.: +98 216 6969 291; mr_sadeqi@yahoo.com** Author for correspondence: Tel.: +98 216 4112 823; afateh2@gmail.comAuthors contributed equally
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T18:40:24.587785+00:00
DOI: 10.2217/fvl-2022-0210 · PMC10348059